000362217010115289

The barcode 000362217010115289 is indeed linked to a product named "Idarubicin." Idarubicin is a chemotherapy drug that is used primarily for treating certain types of cancers, particularly acute myeloid leukemia (AML) and sometimes as part of combination therapy for lymphoma.

Idarubicin functions as an anthracycline antibiotic, which works by intercalating into DNA strands and inhibiting the enzyme topoisomerase II. This mechanism ultimately leads to the disruption of DNA synthesis and promotes cell death, which is critical in targeting cancer cells that are rapidly dividing.

In terms of availability, Idarubicin can be found in various forms including intravenous solutions and potentially capsules, though it's primarily administered in clinical settings. The price for a 100 mg vial or similar quantity can fluctuate, but in the United States, it typically ranges from $200 to $500 for a small package.

Regarding side effects, Idarubicin can cause a range of adverse reactions. Common side effects include nausea, vomiting, hair loss, and more serious concerns like myelosuppression, which is the reduction in bone marrow activity leading to decreased blood cell production. Patients may also experience cardiovascular concerns given the cardiotoxic nature of some anthracyclines.

It is crucial for patients to have thorough discussions with their healthcare providers about the risks, benefits, and monitoring required when undergoing treatment with Idarubicin or any chemotherapy agents.

There are no specific health-related disclaimers mentioned for consumable products in this context, but it is always important to consult with a healthcare professional before starting any new medication.